Omada Health CFO sells 50,950 shares in June

Omada Health, Inc. Chief Financial Officer Steven L. Cook reported selling a total of 50,950 shares of common stock in late June 2026.

Accepted by SEC EDGAR 06/30/2026 - 07:09 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Omada Health, Inc. Chief Financial Officer Steven L. Cook reported selling a total of 50,950 shares of common stock in late June 2026. He executed open-market sales of 33,000 shares at an average price of $19.8924 on June 26 and 17,950 shares at an average price of $21.0678 on June 29. After these sales, he directly holds 115,409 Omada Health shares. One transaction was carried out under a Rule 10b5-1 trading plan that Cook adopted on March 14, 2026, indicating the sale was pre-arranged rather than timed discretionarily.

Insider Trade Summary 10b5-1

Net Seller: 50,950 shares

Net Sell 2 txns

Insider Cook Steven L.

Role Chief Financial Officer

Sold 50,950 shs ($1.03M)

Share of Position Sold 30.6%

Type	Security	Shares	Price	Value
Sale	Common Stock	17,950	$21.0678	$378K
Sale	Common Stock	33,000	$19.8924	$656K

Holdings After Transaction: Common Stock — 115,409 shares (Direct)

Holdings Before and After: Common Stock, 166,359 to 115,409 shares (Direct)

Other Insiders: 3 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (2)

1. F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.
2. F2. This transaction was executed in multiple trades at prices ranging from $19.6727 to $20.078. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Total shares sold: 50,950 shares June 26 sale size: 33,000 shares June 26 average price: $19.8924 per share +5 more

8 metrics

Total shares sold 50,950 shares Net insider sales by CFO in June 2026

June 26 sale size 33,000 shares Open-market sale of common stock on June 26, 2026

June 26 average price $19.8924 per share Weighted average sale price on June 26, 2026

June 29 sale size 17,950 shares Open-market sale of common stock on June 29, 2026

June 29 average price $21.0678 per share Weighted average sale price on June 29, 2026

Shares held after sales 115,409 shares Direct Omada Health common stock held by CFO post-transaction

Price range for one transaction $19.6727–$20.078 per share Multiple trades within this range for one sale

10b5-1 plan adoption date March 14, 2026 Date CFO adopted Rule 10b5-1 trading plan

Key Terms

Rule 10b5-1 trading plan, open-market sale, weighted average price, Form 4

4 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action: "open-market sale" for each common stock transaction."

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

weighted average price financial

"The price reported above reflects the weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Omada Health (OMDA) report for Steven L. Cook?

Omada Health reported that CFO Steven L. Cook sold a total of 50,950 shares of common stock in two open-market transactions in late June 2026, while retaining 115,409 shares directly following these sales.

On which dates did Omada Health (OMDA) CFO Steven L. Cook sell shares?

Steven L. Cook sold 33,000 Omada Health common shares on June 26, 2026, and an additional 17,950 shares on June 29, 2026, according to the Form 4 insider trading report.

What prices did Omada Health (OMDA) CFO receive for his June 2026 stock sales?

Steven L. Cook’s open-market sales were executed at weighted average prices of $19.8924 per share on June 26, 2026, and $21.0678 per share on June 29, 2026, based on the Form 4 disclosure.

How many Omada Health (OMDA) shares does CFO Steven L. Cook hold after these transactions?

Following the reported June 2026 sales, Steven L. Cook directly holds 115,409 shares of Omada Health common stock, as stated in the post-transaction ownership figures in the Form 4 filing.

Were Omada Health (OMDA) CFO stock sales made under a Rule 10b5-1 plan?

One of Steven L. Cook’s transactions was made pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2026, indicating at least part of the selling activity was pre-scheduled rather than discretionary.

What was the trading range for one Omada Health (OMDA) CFO sale?

One transaction was executed in multiple trades within a price range from $19.6727 to $20.078 per share, with the reported sale price reflecting the weighted average across those trades.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cook Steven L.

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/26/2026		S(1)		33,000	D	$19.8924(2)	133,359	D
Common Stock	06/29/2026		S(1)		17,950	D	$21.0678	115,409	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.

2. This transaction was executed in multiple trades at prices ranging from $19.6727 to $20.078. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

	/s/ Nathan Salha, as Attorney-in-Fact for Steven L. Cook	06/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)